The immunoglobulin market size accounted for $9,972.9 million in 2017, and is projected to reach $16,694.7 million by 2025, registering a CAGR of 6.6% from 2018 to 2025.
“Though intravenous mode of delivery dominates the immunoglobulin market, currently the subcutaneous mode of delivery gains popularity due to fewer systemic side-effects and improvement in the quality of life of the patient. In addition, this route is also easier to use for self-administration of immunoglobulin.”
Download Detailed COVID-19 Impact Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/2586?reqfor=covid
Immunoglobulin is a blood/plasma product, which is prepared from the serum of multiple of donors, used to treat patients with antibody deficiency. The isolated plasma product is clinically treated and purified to Ig, which further facilitates the treatment. Immunoglobulin is applicable in various fields such as hematology, immunology, neurology, dermatology, nephrology, ophthalmology, and rheumatology. Prevalence of various antibody deficiency disorders such as common variable immune deficiency (CVID), specific antibody deficiency, and hypogammaglobulinemia, increase in immunoglobulin indications, improved production & purification processes, growth in awareness towards antibody deficiency, and rare immune disorders among patient population drive the growth of the Immunoglobulin market.
Based on application segment, hypogammaglobulinemia was the largest revenue contributor in 2017 towards market growth and is anticipated to continue this trend in the near future. Large patient population, lack of effective substitute treatment, and early adoption of immunoglobulin for the treatment of hypogammaglobulinemia are expected to boost the growth of this segment.
Key Findings of the Immunoglobulin Market:
- Myasthenia Gravis segment is projected to grow at the fastest rate during the analysis period.
- Hypogammaglobulinemia was the highest revenue-generating segment in 2017 and is expected to continue its dominance during the forecast period.
- North America dominated global immunoglobulins market and is projected to grow at a CAGR of 6.3%.
- Saudi Arabia is expected to grow at the fastest rate in the LAMEA region, registering a CAGR of 8.0%.
- LAMEA segment was the fastest growing segment growing at a CAGR of 9.4%.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2586
In 2017, North America accounted for maximum contribution to the total revenue generated, followed by Asia-Pacific. The major factors responsible for the growth of immunoglobulin market in these regions are the high adoption rate in developed and populous countries such as Japan and U.S. and the presence of large plasma production facilities.
The key companies profiled in the report include
- Baxter international Inc.,
- CSL Ltd, Grifols S.A,
- Octapharma AG,
- Kedrion Biopharma Inc.,
- LFB group,
- Biotest AG,
- China Biologics Products Inc.,
- Shire (Baxalta),
- Bayer Healthcare.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
Immunosuppressants Market – Global Opportunity Analysis and Industry Forecast, 2020–2027
Digital Diabetes Management Market – Global Opportunity Analysis and Industry Forecast, 2019-2027
Disposable Syringes Market – Global Opportunity Analysis and Industry Forecast, 2019-2027
Surrogacy Market – Global Opportunity Analysis and Industry Forecast, 2019–2027
U.S. Advanced Wound Care Market – Opportunity Analysis and Industry Forecast, 2019–2027
Menstrual Cup Market – Global Opportunity Analysis and Industry Forecast, 2019–2027
Cell Therapy Market – Global Opportunity Analysis and Industry Forecast, 2019–2027
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research